Nagler A - Search Results

1

Higher busulfan dose intensity appears to improve leukemia-free and overall survival in AML allografted in CR2: An analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

Kharfan-Dabaja MA, Labopin M, Bazarbachi A, Socie G, Kroeger N, Blaise D, Veelken H, Bermudez A, Or R, Lioure B, Beelen D, Fegueux N, Hamladji RM, Nagler A, Mohty M. Kharfan-Dabaja MA, et al. Among authors: nagler a. Leuk Res. 2015 Sep;39(9):933-7. doi: 10.1016/j.leukres.2015.04.009. Epub 2015 Apr 24. Leuk Res. 2015. PMID: 26003666

2

Non-myeloablative hematopoietic stem cell transplantation (NST) in the treatment of human malignancies: from animal models to clinical practice.

Shimoni A, Nagler A. Shimoni A, et al. Among authors: nagler a. Cancer Treat Res. 2002;110:113-36. doi: 10.1007/978-1-4615-0919-6_6. Cancer Treat Res. 2002. PMID: 11908195 Review.

3

Treatment of leukemia by alloreactive lymphocytes and nonmyeloablative stem cell transplantation.

Slavin S, Nagler A, Shapira MY, Aker M, Gabriel C, Or R. Slavin S, et al. Among authors: nagler a. J Clin Immunol. 2002 Mar;22(2):64-9. doi: 10.1023/a:1014423617596. J Clin Immunol. 2002. PMID: 11998894 Review.

4

Kröger N, Sayer HG, Schwerdtfeger R, Kiehl M, Nagler A, Renges H, Zabelina T, Fehse B, Ayuk F, Wittkowsky G, Schmitz N, Zander AR. Kröger N, et al. Among authors: nagler a. Blood. 2002 Dec 1;100(12):3919-24. doi: 10.1182/blood-2002-04-1150. Epub 2002 Aug 8. Blood. 2002. PMID: 12393448 Free article. Clinical Trial.

5

Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phase.

Or R, Shapira MY, Resnick I, Amar A, Ackerstein A, Samuel S, Aker M, Naparstek E, Nagler A, Slavin S. Or R, et al. Among authors: nagler a. Blood. 2003 Jan 15;101(2):441-5. doi: 10.1182/blood-2002-02-0535. Epub 2002 Sep 19. Blood. 2003. PMID: 12393604 Free article.

6

Intra-arterial catheter directed therapy for severe graft-versus-host disease.

Shapira MY, Bloom AI, Or R, Sasson T, Nagler A, Resnick IB, Aker M, Zilberman I, Slavin S, Verstanding A. Shapira MY, et al. Among authors: nagler a. Br J Haematol. 2002 Dec;119(3):760-4. doi: 10.1046/j.1365-2141.2002.03923.x. Br J Haematol. 2002. PMID: 12437655 Free article.

7

Intravenous busulfan-based conditioning prior to allogeneic hematopoietic stem cell transplantation: myeloablation with reduced toxicity.

Shimoni A, Bielorai B, Toren A, Hardan I, Avigdor A, Yeshurun M, Ben-Bassat I, Nagler A. Shimoni A, et al. Among authors: nagler a. Exp Hematol. 2003 May;31(5):428-34. doi: 10.1016/s0301-472x(03)00047-x. Exp Hematol. 2003. PMID: 12763142 Free article.

8

Hematopoietic stem-cell transplantation using umbilical-cord blood.

Cohena Y, Nagler A. Cohena Y, et al. Among authors: nagler a. Leuk Lymphoma. 2003 Aug;44(8):1287-99. doi: 10.1080/1042819031000077016. Leuk Lymphoma. 2003. PMID: 12952221 Review.

9

Cord blood biology and transplantation.

Cohen Y, Nagler A. Cohen Y, et al. Among authors: nagler a. Isr Med Assoc J. 2004 Jan;6(1):39-46. Isr Med Assoc J. 2004. PMID: 14740509 Free article. Review.

10

Umbilical cord blood transplantation--how, when and for whom?

Cohen Y, Nagler A. Cohen Y, et al. Among authors: nagler a. Blood Rev. 2004 Sep;18(3):167-79. doi: 10.1016/S0268-960X(03)00064-X. Blood Rev. 2004. PMID: 15183901 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,456 results

Search Page

Filters